Apollo Hospitals to invest Rs 6,000 crore for 4,300 new beds across India
ADVERTISEMENT Apollo Hospitals will invest Rs 6,000 crores over the next 3-4 years to add more than 4,300 beds across the country, Krishnan Akhileswaran, Group Chief Financial Officer, told ET in an interaction after the company announced its fourth quarter results post market hours on Friday. Out of this, close to 2,000 beds will be added over the next 12-15 months, he said. These will be coming up in places such as Gurugram, Kolkata, Pune, Hyderabad, Delhi and Sarjapur.'In the next four years we would be adding approximately 4,300 beds. We have a total capital outlay of Rs 8,000 crores for the same, of which Rs 2,000 crore is already incurred over the past couple of years when we bought land and some of these assets and the balance Rs 6,000 crore will be incurred over the next four years,' he said.
The expansion will be funded through internal accruals and cash. 'Every year we are generating Rs 1,000 crore of free cash. It should only keep growing, especially given that once we have the new hospitals also next year - most of them being in existing markets where Apollo already has a strong presence - we would be able to see them break even in 12 months,' he added.
For the fourth quarter ended March, the company reported 13% year-on-year increase in consolidated revenue to Rs 5,592 crores, while consolidated net profit grew 54% to Rs 390 crores. Its healthcare services revenue was at Rs 2,822 crores, up 10% YoY, and net profit was at Rs 385 crore; up 37%.For FY25, consolidated revenues rose 14% YoY to Rs 21,794 crores, and net profit was at Rs 1,446 crores, up 61%. Healthcare services revenue for FY25 stood at Rs 11,147 crores, up 13% YoY, while healthcare net profit was up 25% at Rs 1,426 crores.
ADVERTISEMENT The company announced expansion in the Sarjapur micro-market through the addition of 700 beds in two stages, to establish a significant presence in the south-eastern part of Bengaluru with a wide addressable market. The first stage will include acquisition of an existing 200 bedded hospital and the second stage will be to establish a 500-bed greenfield hospital in close proximity.With the ongoing brownfield expansions in the city, the total bed strength in Bengaluru will be 1,500 beds, the company said in a press release.
ADVERTISEMENT 'About 66% of our beds nationally are in the very small format hospitals and not in the organised integrated healthcare sector. The kind of beds that Apollo operates is for high complexity and high equity care and we see continued demand for those kinds of beds,' said Dr Madhu Sasidhar, President & CEO, Apollo Hospitals.Apollo Hospitals, which has 70% of its beds in Metros and 30% in non-metros, had blended average revenue per operating bed (ARPOB) of Rs 63,500 per day for the quarter, one of the highest in the industry, Akhileswaran told ET.
ADVERTISEMENT The company also plans brownfield expansion in Hyderabad by 160 beds through expansion at the existing Jubilee Hills and Secunderabad facilities. Along with the upcoming facility in Gachibowli, Apollo Hospitals' bed strength in Hyderabad will be about 1,400 beds.
The company announced a final dividend of Rs 10 per share, making for a total dividend of Rs 19 per share, on face value of Rs 5 per share.
(You can now subscribe to our ETMarkets WhatsApp channel)
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share
Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained
Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms
Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips
L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first?
Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more
SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders
API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading
Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains
Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains
NEXT STORY
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
13 minutes ago
- The Hindu
From The Hindu, August 7, 1925: Spinning and weaving mills still remain closed
The Anglo-French Textile Mill Co. Ltd., which suspended operations on the 11th of July and the Pondicherry cotton mills which closed its doors on the 1st of July still continue to remain closed. As per notice put up at the gates of the Anglo-French Textile Mills the labourers were paid their fortnightly wages at the rate of Rs. 10 per month. Whether the authorities will continue to do the same after the 11th instant or not remains yet to be seen.
Time of India
28 minutes ago
- Time of India
New bar policy gets AP cabinet nod, allotment through draw of lots
Vijayawada: Andhra Pradesh cabinet on Wednesday approved the new bar policy for three years (2025-28). The govt has fixed the licence fee by dividing the bars into three categories based on the population of the area. Like in retail liquor outlets, the govt has reserved 10% of bar licences for toddy tapers at 50% of the licence fee. The allotment of licence would be done through draw of lots. Anyone can apply for a bar licence by paying the application fee. A minimum of four applications is required for conducting the lottery for a particular area. Announcing the decision, I&PR minister Kolusu Pardasarathi said the new policy was finalised after studying bar policies in neighbouring states. Pardasarathi observed that more than 50% of bars are struggling to stay afloat in the existing policy, which prompted the govt to introduce the new policy. "The 840 existing licences will be renewed according to the new policy. Business hours for the bars have been fixed from 10 am to 11 pm. The existing bar policy will expire on Aug 31, and the new policy will come into effect from Sep 1. The application process and allotment of licences will be completed before Aug 31," he said. The minister further noted that during the YSRCP regime, there was huge difference between the bid prices, leading to cartelisation. "Allotment of licences will be done through a transparent process as the licence fee is fixed for the bars in all three categories," he added. While the licence fee for bars in cities up to 50,000 population has been fixed at Rs 35 lakh per annum, Rs 50 lakh will be charged for bars in cities with population between 50,000 and 5 lakh. The annual licence fee for bars located in cities with more than 5 lakh population has been fixed at Rs 75 lakh. The fee to apply for the bar licence will be Rs 5 lakh. Unlike in the existing system, licence fee can be paid in six equal instalments and submission of bank guarantee equivalent to one instalment. The liquor off take price for bars is fixed on par with retail shops. The cabinet also approved the proposal of granting licences to permit rooms in retail outlets. The licence fee for the permit room has been fixed at Rs 5 lakh per annum. The decision was taken after 2.71 lakh cases of drinking in public places was reported in last one year. This is to ensure that no public inconvenience is caused and also to encourage responsible drinking," Pardasarathi said.
Time of India
28 minutes ago
- Time of India
Prostate health in focus as BPH drug demand rises in Gujarat
Ahmedabad: The sale of drugs used to treat benign prostatic hyperplasia (BPH)—a non-cancerous enlargement of the prostate gland—has surged by 70% over the past four years, indicating a significant rise in cases across the state. According to data from Pharmarack, the moving annual total (MAT) for BPH drugs was Rs 55.24 crore in June 2021, which rose to Rs 93.93 crore in June this year. The MAT for the overall urology segment also saw a 42% increase, from Rs 115.22 crore to Rs 164.2 crore during the same period. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad "BPH affects a significant portion of men aged 50 and above, causing urinary difficulties and impacting quality of life. While the condition has always existed, the sharp rise in diagnosed cases and medical interventions reflects broader trends," said a pharmaceutical distributor who requested anonymity. Industry sources said that pharma companies have improved drug delivery through fixed-dose combinations, leading to better patient compliance and outcomes. The most common prescriptions now include alpha-blockers and 5-alpha-reductase inhibitors, which help alleviate symptoms and slow further prostate growth, Pharmarack data indicated. According to urologists in Ahmedabad, men are increasingly addressing symptoms of an enlarged prostate rather than ignoring them. The stigma around men's urological health is gradually diminishing, especially in urban and semi-urban areas. Dr Rohit Bhattar, a uro-onco surgeon at a city-based private hospital, said, "There has been a significant rise in BPH cases over the past decade. While traditionally considered a disease of old age, we are now seeing some patients even under the age of 50, often due to other health conditions and lifestyle factors. Greater awareness today also plays a role compared to a decade ago." While metros and Tier-I cities initially drove demand for BPH drugs, pharmaceutical industry sources report that Tier-II cities and rural areas are now seeing growing traction. Dr Hemang Bakshi, another uro-onco surgeon, noted, "The rise in drug sales must be viewed in the context of increased life expectancy. Medications are often prescribed to maintain or enhance prostate function over time. Since onset typically occurs around the age of 60, patients may remain on treatment for several years. This extended treatment duration is a contributing factor. We've certainly seen a decadal rise in the incidence of the condition. " Experts say improvements in healthcare access and preventive diagnostics in Gujarat have made a noticeable impact. Routine check-ups, ultrasounds, and PSA tests are increasingly being used to detect prostate issues at earlier stages.
